Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
Heart disease or cardiac disease is the leading cause of death worldwide, affecting both children and adults. The diagnosis and management of heart failure remains challenging despite many advances in recent decades. A key strategy for addressing heart disease and stroke is to educate the public and healthcare practitioners about the importance of prevention. When healthcare providers perform consistent risk factor assessments, more patients can be properly diagnosed and medically managed to prevent cardiac diseases. Both primary and secondary prevention, as well as new developments in the diagnosis, treatment and prevention of cardiac diseases, need to be addressed. Thus, there is a great need for conducting more and more scientific meetings, conferences, symposia's and workshops on this ever growing problem.
OMICS International Organizes 1000+ Global Events, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Scope and Importance:
Cardiac disease is the number one cause of death for both men and women in the United States. It is an equal opportunity killer which claims approximately 1 million lives annually. Cardiovascular diseases claim more lives than all forms of cancer combined. Coronary heart disease is the most common type of heart disease, killing nearly 380,000 people annually. In 2011, about 326,200 people experienced out-of-hospital cardiac arrests in the United States. Of those treated by emergency medical services, 10.6 percent survived. Of the 19,300 bystander-witnessed out-of-hospital cardiac arrests in the same year, 31.4 percent survived. You can help reduce your risk of heart disease by taking steps to control factors that put you at greater risk: Control your blood pressure, lower your cholesterol, don't smoke, get enough exercise.
The EPI/Lifestyle 2015 organized by the American Heart Association has Scientific Sessions which are unique in content and format. The primary goal is to promote the development and application of translational and population science to prevent cardiac disease and stroke and foster cardiovascular health. Conferences on cardiac disease are designed to target clinicians and clinical investigators, interventional cardiologists, noninvasive cardiologists, cardiac surgeons, research associates, basic science investigators (cell and molecular biologists), members of public and private funding organizations, hospital administrators, program directors, legislators, and regulatory agency personnel.
In 2010, over 7.5 million inpatient cardiovascular operations and procedures were performed in the United States alone. During that year, the total inpatient hospital cost for cardiovascular disease was estimated to be $71.2 billion, about one quarter to the total cost of U.S. inpatient hospital care. The American Heart Association further estimates that, by 2030, the total direct medical costs associated with cardiovascular disease in the U.S. alone will increase from an estimated $312.6 million in 2009 to almost $1.5 trillion (in 2010 dollars).
The World Health Organization estimates that 60% of all cardiovascular disease occurs in less developed countries. Recent increase in incidence of cardiovascular disease has been fueled by higher obesity rates in less developed countries; for example, WHO estimates that there are 70 million overweight people in China alone. The global economic burden of coronary heart disease is projected to rise from an estimated 47 million disability adjusted life years in 1990 to an estimated 82 million disability adjusted life years by 2020. This increase will be most acutely felt in nations such as Egypt, India and the republics of the former Soviet Union. The World Health Organization estimates that more than 17.8 million deaths in 2008 were caused by heart disease, accounting for 30% of total global fatalities. Due to the acute nature and rapid progression of heart disease, a number of accurate and quantitative diagnostic assays have been developed to detect the presence of clinically proven biomarkers. According to the report, this market was valued at $3.1 billion in 2012 and nearly $4 billion for 2013. BCC Research expects the market to grow to nearly $7.2 billion by 2018, and register a five-year compound annual growth rate of 12.8% from 2013 to 2018.
6th Clinical & Experimental Cardiology Conference
November 30-December 02, 2015 San Antonio, USA
July 14-15, 2016 Brisbane, Australia
Cardio Vascular Medicine Conference
April 4-6, 2016 Philadelphia, USA
June 06-07, 2016 London, UK
7th Cardiothoracic Meeting
March 29-30, 2016 Atlanta, USA
Ischemic Heart Diseases Conference
May 12-13, 2016 Chicago, USA
July 11-12, 2016 Philadelphia, USA
Hypertension & Treatment Conference
August 04-06, 2016 Toronto, Canada
Molecular & Cellular Cardiology Conference
September 7-9, 2016 Sao Paulo, Brazil
10th Interventional Cardiology Congress
September 12-14, 2016 Berlin, Germany
11th Cardiac Conference
October 6-8, 2016 Vancouver, Canada
12th Cardiology Congress
October 10-12, 2016 Manchester, UK
13th Cardiology Congress
October 24-26, 2016 Valencia, Spain
Cardiovascular Imaging Conference
November 10-12, 2016 Istanbul, Turkey
14th Clinical & Experimental Cardiology Conference
November 14-16, 2016 San Francisco, USA
December 08-10, 2016 San Antonio, USA
18th Annual Cardiology Fiesta: Update on Cardiac Diagnostic and Therapeutic Techniques
August 28-30, 2015 San Antonio, USA
Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Congress
September 26-30, 2015 Lisbon, Portugal
11th International Congress on Coronary Artery Disease
October 11-13 2015 Florence, Italy
3rd International Congress on Cardiovascular Technologies
November 16-17 2015 Lisbon, Portugal
Coronary Artery Disease: Case-Based Learning
November 20-22 2015 Las Vegas, USA
Advances in the Pathogenesisand Management of Cardiovascular Disease
November 27 2015 London, UK
World Congress of Cardiology & Cardiovascular Health
June 04-07, 2016 Mexico City, Mexico
1. Mayo Clinic American Heart Association National Heart, Lung, and Blood
2. Institute British Heart Foundation
3. Citizen CPR Foundation Pierre
4. DuPont-Life Sciences
5. Torrance Memorial Medical Center
International Major Companies
1. Pacific Blue Innovations, LLC.
2. Propepgen Biostrategies Inc.
3. Nextremity Solutions, Inc.
4. Vitae Pharmaceuticals
5. Regeneron Pharmaceuticals
6. Genentech DermTech NIDDK Retrophin
7. Shanghai Sandai Pharmaceutical R & D Co.,Ltd.
This page will be updated regularly.
This page was last updated on 12th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising